{"id":11243,"date":"2022-08-09T12:46:50","date_gmt":"2022-08-09T17:46:50","guid":{"rendered":"https:\/\/scottburrows.com\/?p=11243"},"modified":"2022-08-09T12:46:50","modified_gmt":"2022-08-09T17:46:50","slug":"scott-burrows-pharmaceutical-sales-speaker-3","status":"publish","type":"post","link":"https:\/\/scottburrows.319heads.com\/scott-burrows-pharmaceutical-sales-speaker-3\/","title":{"rendered":"Scott Burrows, Pharmaceutical Sales Speaker"},"content":{"rendered":"
<\/p>\n
<\/p>\n
As a motivational sales speaker for the pharmaceutical industry<\/a>, I tell my audiences that COVID-19 might also be characterized as the disease that changed an industry<\/a>. It is kind of ironic. While the pharmaceutical industry has changed the way medicine has treated nearly every disease known to humankind, it was a virus that changed the way the industry sells.<\/p>\n In the March 2021 article I reference above, the author stated an important fact about the future of pharma sales. Coming out of the pandemic, if the healthcare industry believes it can use AI to replace the role of pharma sales rep or the provider, patient outcomes will not be improved<\/em>. There are still an intangible set of benefits that come from human interaction and cooperation. Nevertheless, it is highly unlikely the industry will ever go back to pre-pandemic days.<\/p>\n